Skip to content
Biodatica
Start free

Institut Cancerologie de l'Ouest

Lille

OncologyPhase I
Compare Sign in to watch

What changed

Study registered, no phase assigned: Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease

8w agoTrial registeredMay 22, 2026Source filing (opens the source filing in a new tab)

Momentum

88no change

Momentum 88 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

701 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    May 1, 2026

    Breast Cancer · NOT_YET_RECRUITING · sponsor: Institut Cancerologie de l'Ouest · Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease

    ClinicalTrials.gov · NCT07601152 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Dec 1, 2025

    Breast Cancer · ACTIVE_NOT_RECRUITING · sponsor: Institut Cancerologie de l'Ouest · Reproductive Health in Breast Cancer Survivor

    ClinicalTrials.gov · NCT06756802 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Feb 1, 2020

    Dry Eye Syndrome, Infectious Keratoconjunctivitis, Mucous Membrane Pemphigoid, Allergic Conjunctivitis · RECRUITING · sponsor: Centre hospitalier de l'Université de Montréal (CHUM) · Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

    ClinicalTrials.gov · NCT04198740 (opens the source filing in a new tab)

  4. Trial

    PHASE1 registered

    Sep 6, 2017

    Sterile Corneal Melt · COMPLETED · sponsor: Centre hospitalier de l'Université de Montréal (CHUM) · Topical Infliximab for Sterile Corneal Melt

    ClinicalTrials.gov · NCT02987686 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources